If state Medicaid programs estimate the costs from expanded use will outweigh the savings, initial state Medicaid participation may be limited, especially given recent state budget challenges and federal funding cuts
according to Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data, 23% of reports included nausea, a reminder that gastrointestinal upset is a common, clinically meaningful event
Discuss with your provider if you frequently miss doses, as this may affect your treatment outcomes and require additional support or planning tools
They get frustrated because it takes several months to escalate the dose to the highest level and see the benefits. Theres no set timeline for when youll start seeing results
This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License
9 The semaglutide group exhibited significant improvements in symptoms and physical limitations, assessed using the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS), with the change in KCCQ-CSS being the primary trial endpoint